HemaSphere (Jun 2022)

P500: A REAL WORLD MULTI CENTRE STUDY OF CPX-351 REVEALS NO DIFFERENCE IN OVERALL SURVIVAL WHEN COMPARED WITH FLAG-IDA AND 3 + 7 IN HIGH RISK AML.

  • C. Andrews,
  • I. AlNabhani,
  • T. Young,
  • E. G. Atenafu,
  • S. E. Assouline,
  • J. M. Brandwein,
  • S. M. Chan,
  • S. Chow,
  • D. Khalaf,
  • V. Gupta,
  • D. D. H. Kim,
  • D. Maze,
  • M. M. Minden,
  • T. Murphy,
  • D. Sanford,
  • A. D. Schimmer,
  • A. C. Schuh,
  • J. Sibai,
  • K. Yee,
  • H. Sibai

DOI
https://doi.org/10.1097/01.HS9.0000844888.58115.a4
Journal volume & issue
Vol. 6
pp. 399 – 400

Abstract

Read online

No abstracts available.